People news

Acceleron Pharma, a biopharmaceutical company developing novel therapeutics that modulate the growth of tissues including bone and muscle, announced that John Knopf, Ph.D., has been named as CEO. Knopf, a founder of Acceleron, has served as the EVP of corporate development and recently, as president, before being unanimously elected by the board as CEO. Prior to co-founding Acceleron, Knopf was formerly site head of the Wyeth Research facilities in Cambridge, MA and VP of metabolic and respiratory disease until 2002. Knopf was also a key scientist at Genetics Institute from 1982 to 1998, where he participated in the development of pioneering biopharmaceutical products and helped establish Genetics Institute as a premier biopharmaceutical company. He also established a structure-based small molecule discovery group at Genetics Institute.
You must be a registered member of MMM to post a comment.

Did you miss January's Top 40 Healthcare Transformers issue? Read how these inventors, strategists, entrepreneurs and wonks are challenging, disrupting and otherwise transforming the healthcare business. And join us April 30 to honor them at the Transforming Healthcare Dinner. Click here.